Kallisio Moves to Close Adoption Gap for 3D Printed Head and Neck Cancer Device
Personalized cancer medtech Kallisio has launched an expanded access program aimed at connecting head and neck cancer patients with Stentra, its FDA-cleared, custom-fit 3D printed intraoral device used during radiation therapy. The program is designed to reach eligible patients directly, even at treatment centers that have not yet adopted the technology. Stentra received FDA 510(k)…
Go to Source
Author: Paloma Duran
